trending Market Intelligence /marketintelligence/en/news-insights/trending/2imvhbvcyzuncnw9w_apsw2 content esgSubNav
In This List

Spectrum Pharmaceuticals appoints chief medical officer

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Spectrum Pharmaceuticals appoints chief medical officer

Spectrum Pharmaceuticals Inc. said it appointed Francois Lebel as chief medical officer, effective Nov. 5.

Most recently, Lebel served as the executive vice president of research and development and chief medical officer at ZIOPHARM Oncology Inc.

Henderson, Nev.-based Spectrum Pharmaceuticals is a biopharmaceutical company that develops and commercializes oncology and hematology drug products.